MétaCan
Menu
Back to cohort
Record W2148428406 · doi:10.1007/s13539-012-0078-2

Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on Sarcopenia

2012· article· en· W2148428406 on OpenAlexaff
Matteo Cesari, Roger A. Fielding, Marco Pahor, Bret H. Goodpaster, Marc K. Hellerstein, Gabor Abellán van Kan, Stefan D. Anker, Seward B. Rutkove, Jan W. Vrijbloed, Maria Isaac, Yves Rolland, Christine M’Rini, Mylène Aubertin‐Leheudre, Jesse M. Cedarbaum, Mauro Zamboni, Cornel Sieber, Didier Laurent, William J. Evans, Ronenn Roubenoff, John E. Morley, Bruno Vellas

Bibliographic record

VenueJournal of Cachexia Sarcopenia and Muscle · 2012
Typearticle
Languageen
FieldMedicine
TopicNutrition and Health in Aging
Canadian institutionsUniversité du Québec à MontréalInstitute of Aging
FundersNational Institute on AgingU.S. Department of Agriculture
KeywordsSarcopeniaClinical trialSkeletal muscleMedicineSocioeconomic statusGerontologyEnvironmental healthPathologyPopulationInternal medicine

Abstract

fetched live from OpenAlex

Sarcopenia, the age-related skeletal muscle decline, is associated with relevant clinical and socioeconomic negative outcomes in older persons. The study of this phenomenon and the development of preventive/therapeutic strategies represent public health priorities. The present document reports the results of a recent meeting of the International Working Group on Sarcopenia (a task force consisting of geriatricians and scientists from academia and industry) held on June 7-8, 2011 in Toulouse (France). The meeting was specifically focused at gaining knowledge on the currently available biomarkers (functional, biological, or imaging-related) that could be utilized in clinical trials of sarcopenia and considered the most reliable and promising to evaluate age-related modifications of skeletal muscle. Specific recommendations about the assessment of aging skeletal muscle in older people and the optimal methodological design of studies on sarcopenia were also discussed and finalized. Although the study of skeletal muscle decline is still in a very preliminary phase, the potential great benefits derived from a better understanding and treatment of this condition should encourage research on sarcopenia. However, the reasonable uncertainties (derived from exploring a novel field and the exponential acceleration of scientific progress) require the adoption of a cautious and comprehensive approach to the subject.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.274
metaresearch head score (Gemma)0.322
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.274
Threshold uncertainty score0.895

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2740.322
Meta-epidemiology (narrow)0.0050.004
Meta-epidemiology (broad)0.0120.012
Bibliometrics0.0100.010
Science and technology studies0.0020.005
Scholarly communication0.0100.009
Open science0.0120.006
Research integrity0.0250.020
Insufficient payload (model declined to judge)0.0040.007

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.222
GPT teacher head0.461
Teacher spread0.239 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations293
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Cachexia Sarcopenia and MuscleSame topicNutrition and Health in AgingFrench-language works237,207